drugset / Trial / NCT01420653

Maxigesic 325 Acute Dental Pain Study

NCT01420653

Phase 3 Completed 408 enrolled AFT Pharmaceuticals, Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether the analgesic effects of Maxigesic USA are greater than acetaminophen, ibuprofen or placebo.

Timeline

Start
2013-04
Primary completion
2014-12
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 975 mg Oral
Comparator Ibuprofen Small molecule 292.5 mg Oral

Indications

No indication recorded.